PGNY - CIK 0001551306
The table below shows Progyny, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $45.95M | $49.81M | $25.73M | $20.96M | -$11.26M | $532.00K |
| Capital expenditure | $6.35M | $2.84M | $850.00K | $1.25M | $790.00K | $369.00K |
| Investing cash flow | $96.59M | -$94.61M | $19.34M | $16.13M | -$39.56M | -$38.52M |
| Dividends paid | - | - | - | - | - |
Progyny, Inc. reported operating cash flow of $210.19M for fiscal year 2025. That is up 17.4% from $179.10M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from -$9.47M (FY 2017) to $210.19M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $118.61M | $0.00 | $23.76M | $0.00 | - | - |
| Financing cash flow | -$123.11M | -$3.29M | -$27.41M | -$1.85M | -$1.77M | -$2.50M |